↓ Skip to main content

Dove Medical Press

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Overview of attention for article published in Clinical Interventions in Aging, November 2009
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
23 Mendeley
Title
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Published in
Clinical Interventions in Aging, November 2009
DOI 10.2147/cia.s8367
Pubmed ID
Authors

Dimitrios A Karagiannis, Ioannis D Ladas, Efstratios Parikakis, Ilias Georgalas, Athanasios Kotsolis, Giorgos Amariotakis, Vasileios Soumplis, Panagiotis Mitropoulos

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 17%
Researcher 4 17%
Other 3 13%
Student > Ph. D. Student 3 13%
Student > Postgraduate 3 13%
Other 4 17%
Unknown 2 9%
Readers by discipline Count As %
Medicine and Dentistry 15 65%
Agricultural and Biological Sciences 2 9%
Nursing and Health Professions 1 4%
Physics and Astronomy 1 4%
Economics, Econometrics and Finance 1 4%
Other 0 0%
Unknown 3 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2018.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Clinical Interventions in Aging
#818
of 1,968 outputs
Outputs of similar age
#38,682
of 108,542 outputs
Outputs of similar age from Clinical Interventions in Aging
#3
of 6 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,968 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,542 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.